Kümler I - Search Results

1

Drug transporters in breast cancer: response to anthracyclines and taxanes.

Kümler I, Stenvang J, Moreira J, Brünner N, Nielsen DL. Kümler I, et al. Expert Rev Anticancer Ther. 2015;15(9):1075-92. doi: 10.1586/14737140.2015.1067610. Expert Rev Anticancer Ther. 2015. PMID: 26313418 Review.

2

Trials of bevacizumab in breast cancer--a safety review.

Kümler I, Nielsen DL. Kümler I, et al. Expert Opin Drug Saf. 2012 May;11 Suppl 1:S37-48. doi: 10.1517/14740338.2011.594038. Epub 2011 Jun 11. Expert Opin Drug Saf. 2012. PMID: 21663533 Review.

3

Efficacy of HER2-targeted therapy in metastatic breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors.

Nielsen DL, Kümler I, Palshof JA, Andersson M. Nielsen DL, et al. Among authors: kumler i. Breast. 2013 Feb;22(1):1-12. doi: 10.1016/j.breast.2012.09.008. Epub 2012 Oct 16. Breast. 2013. PMID: 23084121 Free article. Review.

4

A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancer.

Larsen PB, Kümler I, Nielsen DL. Larsen PB, et al. Among authors: kumler i. Cancer Treat Rev. 2013 Nov;39(7):720-7. doi: 10.1016/j.ctrv.2013.01.006. Epub 2013 Mar 5. Cancer Treat Rev. 2013. PMID: 23481218 Review.

5

A systematic review on topoisomerase 1 inhibition in the treatment of metastatic breast cancer.

Kümler I, Brünner N, Stenvang J, Balslev E, Nielsen DL. Kümler I, et al. Breast Cancer Res Treat. 2013 Apr;138(2):347-58. doi: 10.1007/s10549-013-2476-3. Epub 2013 Mar 20. Breast Cancer Res Treat. 2013. PMID: 23512247 Review.

6

A systematic review of dual targeting in HER2-positive breast cancer.

Kümler I, Tuxen MK, Nielsen DL. Kümler I, et al. Cancer Treat Rev. 2014 Mar;40(2):259-70. doi: 10.1016/j.ctrv.2013.09.002. Epub 2013 Sep 11. Cancer Treat Rev. 2014. PMID: 24080156 Review.

7

Biomarker-guided repurposing of chemotherapeutic drugs for cancer therapy: a novel strategy in drug development.

Stenvang J, Kümler I, Nygård SB, Smith DH, Nielsen D, Brünner N, Moreira JM. Stenvang J, et al. Among authors: kumler i. Front Oncol. 2013 Dec 25;3:313. doi: 10.3389/fonc.2013.00313. Front Oncol. 2013. PMID: 24400218 Free PMC article. Review.

8

A systematic review of bevacizumab efficacy in breast cancer.

Kümler I, Christiansen OG, Nielsen DL. Kümler I, et al. Cancer Treat Rev. 2014 Sep;40(8):960-73. doi: 10.1016/j.ctrv.2014.05.006. Epub 2014 May 22. Cancer Treat Rev. 2014. PMID: 24909311 Review.

9

Clinical outcome of percutaneous RF-ablation of non-operable patients with liver metastasis from breast cancer.

Kümler I, Parner VK, Tuxen MK, Skjoldbye B, Bergenfeldt M, Nelausen KM, Nielsen DL. Kümler I, et al. Radiol Med. 2015 Jun;120(6):536-41. doi: 10.1007/s11547-014-0489-6. Epub 2015 Jan 9. Radiol Med. 2015. PMID: 25572543

10

Topoisomerase-1 gene copy aberrations are frequent in patients with breast cancer.

Kümler I, Balslev E, Poulsen TS, Nielsen SL, Nygård SB, Rømer MU, Christensen IJ, Høgdall E, Moreira J, Nielsen DL, Brünner N, Stenvang J. Kümler I, et al. Int J Cancer. 2015 Oct 15;137(8):2000-6. doi: 10.1002/ijc.29556. Epub 2015 Apr 27. Int J Cancer. 2015. PMID: 25855483

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters